Nutrasource, a global full-service contract research organisation (CRO) has announced a new expansion to its on-site clinical trials facility located in Ontario.

The clinic is just one of the organisation’s sites within its global network of more than 400 clinical trial sites.

Since the expansion — a significant extension of the prior 2019 upgrade — Nutrasource is able to uniquely handle the growing number of concurrent trials in a wide range of specialised therapeutic areas not typically available elsewher in the nutraceutical sector.

These trials will be in addition to the work already being done by the clinical research teams in the natural health product/dietary supplement and pharmaceutical sectors, including omega-3s, probiotics and cannabis, all underpinned by our robust quality management system.

“The expansion of the clinic is part of our ongoing commitment in providing the best work experience and service solutions for our customers,” said William Rowe, President and CEO of Nutrasource.

“This infrastructure growth has more than doubled our capacity and adds clinical tools unique to the nutritional CRO space.”

Notably, Nutrasource also recently ran a decentralised (virtual) trial through the on-site clinic, managed by its team, to successfully screen, enrol and randomise the required 270 participants within 3 months across 47 US states.

The study, which includes the collection of stool samples and questionnaires, continues to display high participant interest and engagement, all while maintaining a low participant attrition rate.

On-site clinic features include

• patient overnight facilities with 24/7 operation
• environmental chamber (vaping, smoking, etc.)
• exercise equipment for sports nutrition, pain and inflammation models
• enhanced level of pharmacy security
• two early phase units and Phase II/III outpatient unit
• full metabolic kitchen
• complete sample preparation and processing lab (blood, urine, stool, saliva, cell preparation, etc.)
• remote clinical trial command centre.